1. Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

   • Uchechukwu K. Sampson
   • Sergio Fazio
   • MacRae F. Linton

   Statin Drugs (M Clearfield, Section Editor) 19 November 2011 Pages: 1 - 10

   

2. Treatment of Familial Hypercholesterolemia: Is There a Need Beyond Statin Therapy?

   • Anna Raper
   • Daniel M. Kolansky
   • Marina Cuchel

   Statin Drugs (M Clearfield, Section Editor) 02 December 2011 Pages: 11 - 16

3. Initiation of Statin Therapy: Are There Age Limits?

   • Dipan A. Desai
   • Sammy Zakaria
   • Pamela Ouyang

   Statin Drugs (M Clearfield, Section Editor) 16 November 2011 Pages: 17 - 25

   

4. Role of C-Reactive Protein When Prescribing a Statin

   • Scott Kinlay

   Statin Drugs (M Clearfield, Section Editor) 29 November 2011 Pages: 26 - 32

   

5. A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough

   • Jeffrey G. Shanes

   Statin Drugs (M Clearfield, Section Editor) Open access 23 November 2011 Pages: 33 - 40

6. New Horizons for Cholesterol Ester Transfer Protein Inhibitors

   • Gregory G. Schwartz

   Nonstatin Drugs (W Borden, Section Editor) 15 November 2011 Pages: 41 - 48

   

7. Niacin: The Evidence, Clinical Use, and Future Directions

   • Todd C. Villines
   • Andrew S. Kim
   • Allen J. Taylor

   Nonstatin Drugs (W Borden, Section Editor) 27 October 2011 Pages: 49 - 59

   

8. Advances in Medical Therapy for Weight Loss and the Weight-Centric Management of Type 2 Diabetes Mellitus

   • Leon I. Igel
   • Amanda G. Powell
   • Louis J. Aronne

   Nonstatin Drugs (W Borden, Section Editor) 24 November 2011 Pages: 60 - 69

9. Lipid Effects of Antihypertensive Medications

   • Roderick Deano
   • Matthew Sorrentino

   Nonstatin Drugs (W Borden, Section Editor) 27 October 2011 Pages: 70 - 77

10. Novel Antiplatelet Therapies

    • Luke Kim
    • Konstantinos Charitakis
    • Dmitriy N. Feldman

    Nonstatin Drugs (W Borden, Section Editor) 19 November 2011 Pages: 78 - 84

11. Pharmacologic Agents for Tobacco Dependence Treatment: 2011 Update

    • J. Taylor Hays
    • David D. McFadden
    • Jon O. Ebbert

    Nonstatin Drugs (W Borden, Section Editor) 15 October 2011 Pages: 85 - 92

12. Erratum to: Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

    • Melissa Y. Wei
    • Terry A. Jacobson

    Erratum 03 December 2011 Pages: 93 - 93